price
ME
NASDAQ · MESO
Mesoblast Limited
Healthcare · Biotechnology
$15.48
Down-$0.02 (-0.13%)
Updated Sep 13, 2026, 11:17 PM
SID Score
4.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.36B
- P/E ratio
- -27.76
- Dividend yield
- 0.00%
- 52-week range
- $13.05 – $21.50
- Volume
- 180.17K
- Avg. volume
- 231.33K
Price performance
MESO price history
1M range · 19 trading sessions · Daily adjusted prices
MESO closed at $15.48 after 19 trading sessions, down 9.05% for the selected period.
- Last close
- $15.48
- Period change
- -9.05%
- Period low
- $15.48
- Period high
- $18.18
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $15.57 | $15.65 | $15.425 | $15.48 | 180.17K |
| Sep 10, 2026 | $15.80 | $15.80 | $15.45 | $15.50 | 182.07K |
| Sep 9, 2026 | $16.25 | $16.25 | $15.965 | $16.14 | 200.02K |
| Sep 8, 2026 | $16.71 | $16.72 | $16.39 | $16.39 | 151.38K |
| Sep 4, 2026 | $17.04 | $17.335 | $17.03 | $17.32 | 93.5K |
| Sep 3, 2026 | $17.27 | $17.29 | $16.935 | $17.14 | 86.06K |
| Sep 2, 2026 | $16.98 | $17.40 | $16.98 | $17.29 | 296.63K |
| Sep 1, 2026 | $16.63 | $16.69 | $16.45 | $16.50 | 169.08K |
| Aug 31, 2026 | $16.92 | $16.95 | $16.63 | $16.76 | 173.73K |
| Aug 28, 2026 | $17.81 | $18.08 | $17.33 | $17.44 | 234.74K |
| Aug 27, 2026 | $17.82 | $18.33 | $17.3767 | $18.18 | 541.63K |
| Aug 26, 2026 | $17.08 | $17.08 | $16.67 | $16.84 | 108.42K |
| Aug 25, 2026 | $16.73 | $17.22 | $16.73 | $17.19 | 148.04K |
| Aug 24, 2026 | $16.80 | $16.80 | $16.44 | $16.64 | 177.71K |
| Aug 21, 2026 | $16.98 | $17.11 | $16.81 | $17.00 | 164.75K |
| Aug 20, 2026 | $17.70 | $17.97 | $17.41 | $17.43 | 273.59K |
| Aug 19, 2026 | $16.85 | $17.14 | $16.78 | $17.13 | 132.46K |
| Aug 18, 2026 | $16.91 | $17.06 | $16.60 | $16.67 | 182.26K |
| Aug 17, 2026 | $17.21 | $17.48 | $16.84 | $17.02 | 458.4K |
Latest MESO news
The latest Smart Investors Daily articles mentioning MESO.
Stock researchMarket Activity · Options
Loading stock research…

